Nexterone approved for arrhythmias - ONA
Links shared publicly online about this topic.
- 718total visits
Nexterone approved for arrhythmias - ONA
View full resource at oncologynurseadvisor.com
Tags: Heart Disease, Arrhythmia, Ventricular Fibrillation, Pharma, FDA, Antiarrhythmic Medication, Cordarone
Most Recently Shared on November 18, 2010 at 2:42 pm By:
Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter
news-medical.net — “Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 2:05 pm By:
Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter: Boston Scientific Corporation tod... http://t.co/ZtVd5Sce
Medical News: FDA Orders Safety Review of Pradaxa - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA said it will begin a safety review of reports of excess bleeding associated with dabigatran (Pradaxa), an oral direct thrombin inhibitor that is approved for prevention of stroke” View full resource at medpagetoday.com
Most Recently Shared on January 10, 2012 at 1:34 am By:
@InpatientMed You mean, besides the uncontrollable bleeding thing? :) http://t.co/gY3CDseQ
Medical News: Public Citizen Calls on FDA to Nix Xarelto - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “The consumer group Public Citizen has asked the FDA not to approve rivaroxaban (Xarelto) for use in patients with atrial fibrillation because of safety and efficacy concerns.” View full resource at medpagetoday.com
Most Recently Shared on October 21, 2011 at 5:08 pm By:
Public Citizen calls on FDA to nix Xarelto: http://t.co/rwTVn8uf
Cryoablation used to successfully treat atrial fibrillation in Canada
sciencedaily.com — “The electrophysiology team at the Montreal Heart Institute used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity. This was a first in Canada following the approval of the Arctic Front device by Health Canada.” View full resource at sciencedaily.com
Most Recently Shared on May 11, 2011 at 1:11 pm By:
ScienceDaily: Cryoablation used to successfully treat atrial fibrillation in Canada http://bit.ly/j0Cnu4 Full http://bit.ly/jy23lS
Baxter nabs Prism's arrythmia drug in $338M buyout - FierceBiotech
fiercebiotech.com — “Just months after gaining an FDA approval for ready-to-use IV formulations of its anti-arrhythmic agent Nexterone, Prism Pharmaceuticals has sealed a $338 million buyout deal with Baxter Read more...” View full resource at fiercebiotech.com
Most Recently Shared on April 18, 2011 at 3:20 pm By:
Baxter nabs Prism's arrythmia drug in $338M buyout. http://bit.ly/eijgEe
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection
drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 22, 2010 at 10:07 pm By:
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection:... http://bit.ly/e5xFxU #drug
Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection
drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 22, 2010 at 9:51 pm By:
FDA Approves Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection - http://bit.ly/eLpm0Y
Medical News: Dabigatran: The Case of the Missing 110-mg Dose - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “The mystery surrounding the doses of dabigatran (Pradaxa) approved this week by the FDA has not yet been fully solved, but the FDA has provided a partial answer.” View full resource at medpagetoday.com
Most Recently Shared on October 21, 2010 at 9:00 pm By:
The missing 110 mg dose of dabigatran: MedPage http://bit.ly/9XVTld
Medical News: Dabigatran: The Case of the Missing 110-mg Dose - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “The mystery surrounding the doses of dabigatran (Pradaxa) approved this week by the FDA has not yet been fully solved, but the FDA has provided a partial answer.” View full resource at medpagetoday.com
Most Recently Shared on October 21, 2010 at 8:08 pm By:
Dabigatran: The Case of the Missing 110-mg Dose: (MedPage Today) -- The mystery surrounding the doses of dabigatra... http://bit.ly/c4DcIZ
Dabigatran approved for AF | theheart.org
theheart.org — “Latest developments and findings in Arrhythmia/EP and Electrophysiology studies from Heartwire news and prominent cardiologists.” View full resource at theheart.org
Most Recently Shared on October 20, 2010 at 3:39 pm By:
theheart.org readers are jabbering about the dose choices in yesterday's dabigatran approval--join the fray: http://bit.ly/csLQNS
Medical News: Dabigatran Wins FDA Nod for Stroke Prevention in Afib Patients - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “WASHINGTON -- The anticoagulant drug dabigatran (Pradaxa) can be marketed for preventing strokes and thrombosis in patients with atrial fibrillation, the FDA announced.” View full resource at medpagetoday.com
Most Recently Shared on October 20, 2010 at 2:06 am By:
Dabigatran approved for stroke prevention in a-fib as an oral med alternative to warfarin with no need for monitoring http://bit.ly/bZPJ79
Dabigatran approved for AF | theheart.org
theheart.org — “Latest developments and findings in Arrhythmia/EP and Electrophysiology studies from Heartwire news and prominent cardiologists.” View full resource at theheart.org
Most Recently Shared on October 20, 2010 at 1:10 am By:
FDA approves dabigatran for stroke prevention, embolism, in AF patients: The long wait for an alternative to warfa... http://bit.ly/9aYYOm
$10.5 Million Grant To Initiate Nationwide Clinical Trial Of Chest Pain Drug For Arrhythmias
medicalnewstoday.com — “A drug approved to treat chest pain is being tested as a potential treatment for ventricular arrhythmias, irregular heart rhythms that are associated with increased hospitalizations and death and” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2010 at 11:26 am By:
MedicalNewsToday: $10.5 Million Grant To Initiate Nationwide Clinical Trial Of Chest Pain: http://bit.ly/adk1Pq Full http://bit.ly/aYfhkG
New IV antiarrhythmic drug approved in EU for rapid conversion of AF | theheart.org theheart.org: Arrhythmia/EP, Electrophysiology news and education
theheart.org — “Latest developments and findings in Arrhythmia/EP and Electrophysiology studies from Heartwire news and prominent cardiologists.” View full resource at theheart.org
Most Recently Shared on September 9, 2010 at 9:47 pm By:
Vernakalant cleared in EU for conversion of AF to sinus rhythm: A novel intravenous drug, vernakalant, has been ap... http://bit.ly/aWNTaF
Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval
news-medical.net — “Medtronic, Inc. today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency ablation technology for the treatment of atrial fibrillation. AF is the most common heart arrhythmia that affects more than 250,000 Canadians and seven million people worldwide.” View full resource at news-medical.net
Most Recently Shared on August 26, 2010 at 5:23 pm By:
Stroke News: Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval: Medtronic, In... http://twurl.nl/8hglry
Advertisement

